期刊文献+

左旋黄皮酰胺对冈田酸和β淀粉样肽_(25-35)神经毒性的保护作用 被引量:9

Protective effect of(-)clausenamide against neurotoxicity induced by okadaic acid and β-amyloid peptide_(25-35)
下载PDF
导出
摘要 探讨左旋黄皮酰胺对冈田酸(okadaic acid,OA)诱导的人神经瘤细胞(SH-SY5Y)和去卵巢(ovariectomy,OVX)及单侧侧脑室注射Aβ25-35所致神经元损伤的保护作用。通过MTT试验、LDH释放测定试验、Hoechst 33258荧光染色试验以及SH-SY5Y细胞检测,考察左旋黄皮酰胺拮抗冈田酸诱导的细胞毒作用。通过避暗试验、电镜检测、Nissl体染色及HE染色,考察左旋黄皮酰胺对去卵巢及侧脑室注射Aβ25-35大鼠神经元的保护作用。左旋黄皮酰胺可明显拮抗冈田酸诱导的细胞毒作用,提高去卵巢及侧脑室注射Aβ25-35大鼠的学习记忆能力,保护海马及皮层神经元。左旋黄皮酰胺可拮抗冈田酸及Aβ25-35诱导的神经毒性,具有神经保护作用。 This study is to investigate the protective effect of (-) clausenamide against the neurotoxicity of okadaic acid in SH-SY5Y cell line, and injection β-amyloid peptide(25-35) (Aβ(25-35)) to the cerebral ventricle in ovariectomy (OVX) rats. MTT assay, LDH assay, and Hoechst 33258 staining were used to detect the effect of ( - )clausenamide on the toxicity of okadaic acid in SH-SY5Y cell line. The animal model was induced by ovariectomized and injection of Aβ(25-35) in the cerebroventricle of rats. The effect of ( - )clausenamide on learning and memory deficiency was observed by step-through test. Electron microscope, Nissl body staining, and HE staining were used to examine the morphological changes in hippocampus and cerebral cortex neurons. Pretreatment of ( - )clausenamide and LiCl decreased the rate of cell death from MTT, LDH release, and apoptosis from Hoechst 33258 staining in SH-SY5Y cell line. The step-through tests showed ( - )clausenamide could improve the ability of learning and memory. The Nissl body staining and HE staining experiments also showed the neuroprotective effects of (-) clausenamide on the neurons of hippocampus and cerebral cortex. ( - )Clausenamide has the protective effects against the neurotoxicity induced by okadaic acid and Aβ(25-35).
出处 《药学学报》 CAS CSCD 北大核心 2007年第9期935-942,共8页 Acta Pharmaceutica Sinica
关键词 左旋黄皮酰胺 阿尔茨海默病 冈田酸 β淀粉样肽(25-35) 神经保护作用 ( - ) clausenamide Alzheimer' s disease okadaic acid β-amyloid peptide(25-35) neuroprotective effect
  • 相关文献

参考文献18

  • 1Selkoe DJ.The molecular pathology of Alzheimer's disease[J].Neuron,1991,6:487-498.
  • 2Tang K,Zhang JT.(-)Clausenamide improves long-term potentiation impairment and attenuates apoptosis after transient middle cerebral artery occlusion in rats[J].Neurol Rev,2003,25:713-717.
  • 3Duan WZ,Zhang JT.Inhibition of (-),(+)clausenamide to acetylcholinesterase[J].Chin J Pharmacol Toxicol,1998,12:16-19.
  • 4Paxinos G,Watson C.The rat brain in stereotaxic coordinates[M].Australia:Academic Press,1986:21.
  • 5Tanaka T,Zhong J,Iqbal K,et al.The regulation of phosphorylation of tau in SY5Y neuroblastoma cells:the role of protein phosphatases[J].FEBS Lett,1998,426:248-254.
  • 6Alvarez G,Munoz-Montano JR,Satrustegui J,et al.Regulation of tau phosphorylation and protection against β-amyloid-induced neurodegeneration by lithium.Possible implications for Alzheimer's disease[J].Bipolar Disord,2002,4:153-165.
  • 7Gong CX,Lidsky T,Wegiel J,et al.Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain.Implications for neurofibrillary degeneration in Alzheimer's disease[J].J Biol Chem,2000,275:5535-5544.
  • 8Chuang DM.Neuroprotective and neurotrophic actions of the mood stabilizer lithium:can it be used to treat neurodegenerative disease?[J].Crit Rev Neurobiol,2004,16:83-90.
  • 9Chuang DM,Chen RW,Chalecka-Franaszek E,et al.Neuroprotective effects of lithium in cultured cells and animal models of diseases[J].Bipolar Disord,2002,4:129-136.
  • 10Hong M,Chen DC,Klein PS,et al.Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3[J].J Biol Chem,1997,272:25326-25332.

二级参考文献2

共引文献27

同被引文献59

引证文献9

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部